SEP 13, 2020 10:50 AM PDT

Scientists Find Way to Reduce Inflammation from Vaccines

WRITTEN BY: Annie Lennon

Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a key ingredient in modern vaccines that helps create an immuno-response that protects against various diseases. 

While adjuvants are useful for activating inflammatory cytokines that are then able to protect against various diseases, some cause an excessive inflammatory response in the body and are thus difficult to implement in vaccine development. As such, the researchers behind the present study wanted to find a way to limit the possibility of inflammation while still guaranteeing the desired immune response. 

After some searching, they came across a peptide known as SN50, which, as tests demonstrated, had the potential to disrupt pathways in cells that typically lead to excessive inflammation. In particular, this molecule seemed to interrupt a protein called NF-kB, known to produce inflammatory cytokines. Adding the molecule to a range of drugs, they found it was able to reduce inflammation and increase antibodies against various diseases in mouse models. 

In mice with dengue, for example, they found that the molecule helped the body produce more antibodies to neutralize the virus. Meanwhile, in those with HIV, they found it also helped produce more antibodies that targeted hard-to-reach areas of the virus. It was also able to enhance a pre-existing flu vaccine's efficacy. 

The next step for the researchers is to find whether a molecule smaller than a peptide is able to produce the same results. They also want to investigate how such a molecule could aid immunotherapy treatments for cancer and other health conditions. In particular, they say that their research has many implications for how vaccines may be designed in the next 5- 10 years, and could one day aid in the development of vaccines against SARS-CoV-2, especially if it becomes a seasonal threat. 

 

Sources: Neuroscience NewsScience Advances

 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAY 04, 2021
Cell & Molecular Biology
A Potential Weakness in SARS-CoV-2 is Caught on Video
MAY 04, 2021
A Potential Weakness in SARS-CoV-2 is Caught on Video
You can see the spike protein of the virus in action in this video.
MAY 12, 2021
Cardiology
Reversing the Heart Damage Seen in Marfan Syndrome
MAY 12, 2021
Reversing the Heart Damage Seen in Marfan Syndrome
Marfan syndrome is a genetic disorder that disrupts the connective tissues that anchor and link the body's organs, affec ...
MAY 28, 2021
Cell & Molecular Biology
Some Animals Can Breathe Through Their Whats?
MAY 28, 2021
Some Animals Can Breathe Through Their Whats?
There are some aquatic animals like sea cucumbers and some types of catfish that can survive in environments with limite ...
JUL 22, 2021
Drug Discovery & Development
Enhancing Myelin to Treat Alzheimer's Disease
JUL 22, 2021
Enhancing Myelin to Treat Alzheimer's Disease
Brain cells, or neurons, communicate through electrochemical signals. The electrical signals travel down a neuron’ ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
JUL 29, 2021
Drug Discovery & Development
A low-cost drug for the treatment of hepatitis.
JUL 29, 2021
A low-cost drug for the treatment of hepatitis.
      The viral disease, Hepatitis C, is known as a silent killer. Hepatitis C is easily spread thro ...
Loading Comments...